MedPath

Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain

Completed
Conditions
Chronic Pain
Interventions
Device: Quantitative Sensory Testing (QST)
Registration Number
NCT00656942
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The MGH Center for Translational Pain Research is seeking patients with chronic pain for a research study. The study is looking at the effect of opioid (narcotic) pain medicines on pain sensation, threshold and tolerance.

Detailed Description

The study consists of one visit, in which an interview, physical exam, lab work (urine test) and sensory testing will be done. The testing (Quantitative Sensory Testing) is noninvasive (no needles) and involves heat and cold stimulation. Compensation and some parking reimbursement provided.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
419
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pain, opioidQuantitative Sensory Testing (QST)* subjects have chronic pain and have been taking opioid medication for at least 3 months * subjects receive QST
Pain, no opioidQuantitative Sensory Testing (QST)* subjects have chronic pain but have not taken any opioid medication for at least 3 months * subjects receive QST
HealthyQuantitative Sensory Testing (QST)* subjects with no pain and no opioid treatment for at least six months * subjects receive quantitative sensory testing (QST)
Primary Outcome Measures
NameTimeMethod
Response to warm/cold temperature2 hours

Responses to warm/cold temperatures will be recorded by the Quantitative Sensory Testing device (QST).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MGH Center for Translational Pain Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath